Ltd Chione serves as Executive at Karyopharm Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Ltd Chione has executed 8 insider transactions totaling $4.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 14, 2023 involved selling 893 shares valued at $10.8K.
Ltd Chione currently holds 3,850,704 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ltd Chione has been a net seller of KPTI stock. They have purchased $0 and sold $4.6M worth of shares.
Ltd Chione's most recent insider trade was on Jun 14, 2023, when they sold 893 shares at $12.13 per share.
Get notified when new Form 4 filings are submitted
| $12.30 |
| Discretionary |
| Jun 12, 2023 | ACRV | $24.7K | Sale | 2,000 | $12.34 | Discretionary |
| Aug 29, 2018 | KPTI | $3.9M | Sale | 200,000 | $19.59 | Discretionary |
| Aug 27, 2018 | KPTI | $259.8K | Sale | 14,026 | $18.52 | Discretionary |
| Aug 10, 2018 | KPTI | $13.0K | Sale | 702 | $18.50 | Discretionary |
| Jun 7, 2016 | KPTI | $185.0K | Sale | 20,000 | $9.25 | Discretionary |
| Jun 6, 2016 | KPTI | $184.4K | Sale | 20,000 | $9.22 | Discretionary |